Back to Search
Start Over
Age-dependent favorable visual recovery despite significant retinal atrophy in pediatric MOGAD: how much retina do you really need to see well?
- Source :
-
Journal of neuroinflammation [J Neuroinflammation] 2021 May 29; Vol. 18 (1), pp. 121. Date of Electronic Publication: 2021 May 29. - Publication Year :
- 2021
-
Abstract
- Background: To investigate age-related severity, patterns of retinal structural damage, and functional visual recovery in pediatric and adult cohorts of myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) optic neuritis (ON).<br />Methods: All MOGAD patients from the 5 participating centers were included. Patients with initial manifestation <18 years were included in the pediatric (MOGAD <superscript>ped</superscript> ) cohort and patients with ≥18 years in the adult (MOGAD <superscript>adult</superscript> ) cohort. For patients with MOGAD ON, examinations at least ≥6 months after ON onset were included in the analyses. Using spectral domain optical coherence tomography (SD-OCT), we acquired peripapillary retinal nerve fiber layer thickness (pRNFL) and volumes of combined ganglion cell and inner plexiform layer (GCIPL). High- and 2.5% low-contrast visual acuity (HCVA, LCVA) and visual-evoked potentials (VEP) were obtained.<br />Results: Twenty MOGAD <superscript>ped</superscript> (10.3±3.7 years, 30 MOGAD ON eyes) and 39 MOGAD <superscript>adult</superscript> (34.9±11.6 years, 42 MOGAD ON eyes) patients were included. The average number of ON episodes per ON eye was similar in both groups (1.8±1.3 and 2.0±1.7). In both pediatric and adult MOGAD, ON led to pronounced neuroaxonal retinal atrophy (pRNFL: 63.1±18.7 and 64.3±22.9 μm; GCIPL: 0.42±0.09 and 0.44±0.13 mm <superscript>3</superscript> , respectively) and moderate delay of the VEP latencies (117.9±10.7 and 118.0±14.5 ms). In contrast, visual acuity was substantially better in children (HCVA: 51.4±9.3 vs. 35.0±20.6 raw letters, p=0.001; LCVA: 22.8±14.6 vs. 13.5±16.4, p=0.028). Complete visual recovery (HCVA-logMAR 0.0) occurred in 73.3% of MOGAD <superscript>ped</superscript> and 31% MOGAD <superscript>adults</superscript> ON eyes, while 3.3% and 31% demonstrated moderate to severe (logMAR > 0.5) visual impairment. Independent of retinal atrophy, age at ON onset significantly correlated with visual outcome.<br />Conclusion: Pediatric MOGAD ON showed better visual recovery than adult MOGAD ON despite profound and almost identical neuroaxonal retinal atrophy. Age-related cortical neuroplasticity may account for the substantial discrepancy between structural changes and functional outcomes.
- Subjects :
- Adolescent
Adult
Age Factors
Atrophy immunology
Child
Child, Preschool
Cohort Studies
Evoked Potentials, Visual
Female
Humans
Male
Middle Aged
Myelin-Oligodendrocyte Glycoprotein immunology
Optic Neuritis complications
Optic Neuritis immunology
Recovery of Function
Retinal Degeneration immunology
Retinal Degeneration physiopathology
Tomography, Optical Coherence
Vision Disorders immunology
Autoimmune Diseases of the Nervous System classification
Autoimmune Diseases of the Nervous System complications
Autoimmune Diseases of the Nervous System diagnostic imaging
Optic Neuritis physiopathology
Retina diagnostic imaging
Retina immunology
Retina physiopathology
Vision Disorders physiopathology
Visual Acuity immunology
Subjects
Details
- Language :
- English
- ISSN :
- 1742-2094
- Volume :
- 18
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Journal of neuroinflammation
- Publication Type :
- Academic Journal
- Accession number :
- 34051804
- Full Text :
- https://doi.org/10.1186/s12974-021-02160-9